Members
Stefan Laufer, PhD.
(Current Chairman) http://www.medchem.uni-tuebingen.de
- Chair Pharmaceutical/Medicinal Chemistry, Tübingen University
- 30 years in small molecule drug discovery & development (10a industry)
- 400 publications, 40 patent families, 3 candidates from bench to bedside (first into man)
- Strong interdisciplinary background (pharmacogenomics, academic drug discovery)
Wolfgang Albrecht, PhD.
- Biotechnologist (Dr.-Ing.), Consultant for TüCAD2, Chemical Research Director TEVA
- 20+ years in pharmaceutical industry (drug discovery, non-clinical and clinical DMPK, pharm./tox., API development
- Co-Founder and CEO of two spin-offs, both VC and publicly funded
Heike Brötz-Oesterhelt, Ph.D
- Chair for Microbial Bioactive Compounds at Tübingen University
- Record in natural product antibiotics in both industry and academia
- Novel lead structures from natural sources for antibacterial drug discovery
- Discovery of novel targets for antibiotic action
- Co-Inventor of a resistance-breaking hospital antibiotic (currently Phase I clinical trials)
Antti Poso, PhD.
- Pharmaceutical Chemist; background in Molecular Modelling, in silico screening, docking
- 3D-QSAR; Track record in industry co-operations and spin-offs
- Department of Pharmaceutical Chemistry, University of Kuopio
Lars Zender, M.D
Innere Medizin VIII - Klinische Tumorbiologie
- Medical Director Department Internal Medicine VIII
- Clinical focus: Medicinal oncology and Hepatology
- Scientific focus: molecular biology, translational medicine, animal models of liver disease and liver cancer
- Awardee of the Gottfried Wilhelm Leibniz-Preis and recipient of an ERC Consolidator grant.
Associated Partnerships:
ICEPHA, Tuebingen/Stuttgart
IKP Stuttgart
ZPM Tuebingen
CCC Tuebingen-Stuttgart
Collaboration Partners in Tuebingen:
Ingo Autenrieth
Nisar Malek
Samuel Wagner
Meinrad Gawaz
Monika Schuetz
Michael Schindler
Klaus Schultze-Osthoff
Alfred Nordheim
Ulrich Lauer
Frank Boeckler
Michael Laemmerhofer
Rolf Daniels